ARTICLE | Distillery Therapeutics
Increasing WWTR1 degradation for NASH
May 28, 2020 7:24 PM UTC
INDICATION: Non-alcoholic steatohepatitis (NASH)...
BCIQ Company Profiles
INDICATION: Non-alcoholic steatohepatitis (NASH)...
BCIQ Company Profiles
BCIQ Company Profiles